IDYA - IDEAYA Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$58.67
DETAILS
HIGH:
$65.00
LOW:
$53.00
MEDIAN:
$58.00
CONSENSUS:
$58.67
UPSIDE:
101.62%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue | 218.7 | 7 | 23.4 | 50.9 | 27.9 | 19.5 | 0 | 0 | 0 |
| Cost of Revenue | 4.6 | 3.8 | 4.0 | 2.1 | 1.7 | 1.4 | 1.2 | 0.9 | 0.4 |
| Gross Profit | 214.1 | 3.2 | 19.4 | 48.8 | 26.2 | 18.2 | (1.2) | (0.9) | (0.4) |
| Operating Expenses | |||||||||
| R&D Expenses | 314.7 | 294.7 | 129.5 | 89.5 | 58.2 | 39.7 | 34.3 | 31.7 | 12.4 |
| SG&A Expenses | 63.3 | 35.5 | 24.3 | 21.8 | 18.3 | 13.8 | 8.7 | 3.8 | 1.7 |
| Other Expenses | (4.6) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 373.4 | 330.1 | 153.8 | 111.3 | 76.5 | 53.5 | 43.0 | 35.5 | 14.0 |
| Operating Income | |||||||||
| Operating Income | (159.3) | (327.0) | (134.4) | (62.5) | (50.3) | (35.3) | (44.3) | (36.4) | (14.4) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 45.6 | 52.5 | 21.5 | 3.8 | 0.5 | 0.8 | 2.3 | 2.0 | 0.1 |
| Profitability | |||||||||
| EBITDA | (154.7) | (270.6) | (109.0) | (56.6) | (48.0) | (33.1) | (40.7) | (33.5) | (11.5) |
| EBIT | (159.3) | (274.5) | (113.0) | (58.7) | (49.8) | (34.5) | (42.0) | (34.3) | (11.9) |
| Income Before Tax | (113.7) | (274.5) | (113.0) | (58.7) | (49.8) | (34.5) | (42.0) | (34.3) | (11.9) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (113.7) | (274.5) | (113.0) | (58.7) | (49.8) | (34.5) | (42.0) | (34.3) | (11.9) |
| Per Share Data | |||||||||
| EPS (Basic) | -1.28 | -3.36 | -1.96 | -1.42 | -1.41 | -1.31 | -1.90 | -2.41 | -0.83 |
| EPS (Diluted) | -1.28 | -3.36 | -1.96 | -1.42 | -1.41 | -1.31 | -1.90 | -2.41 | -0.83 |
| Shares Outstanding | 88.5 | 81.7 | 57.5 | 41.4 | 35.3 | 24.7 | 20.2 | 14.2 | 14.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash & Cash Equivalents | 112.8 | 84.4 | 157.0 | 68.6 | 92.0 | 72.0 | 34.1 | 20.5 | 6.0 |
| Short-Term Investments | 526.6 | 591.9 | 368.1 | 296.2 | 154.7 | 211.5 | 64.9 | 69.5 | 7.2 |
| Net Receivables | 0 | 0.0 | 0.0 | 0.2 | 1.1 | 1.9 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 27.3 | 13.4 | 7.5 | 5.4 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 666.7 | 689.7 | 532.6 | 370.5 | 251.0 | 288.6 | 101.7 | 90.7 | 13.6 |
| Non-Current Assets | |||||||||
| Property, Plant & Equipment | 31.3 | 27.7 | 8.4 | 9.0 | 8.7 | 9.5 | 9.7 | 5.2 | 3.7 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 405.8 | 107.5 | 8.3 | 121.3 | 0 | 1.5 | 0 | 0.1 |
| Other Non-Current Assets | 411.3 | 0.8 | 0.8 | 0.2 | 0.4 | 0.2 | 0.1 | 0.7 | 0.1 |
| Total Non-Current Assets | 442.6 | 434.4 | 116.7 | 17.5 | 130.4 | 9.7 | 11.3 | 5.9 | 3.9 |
| Total Assets | 1,109.3 | 1,124.1 | 649.3 | 388.0 | 381.3 | 298.3 | 113.0 | 96.5 | 17.5 |
| Current Liabilities | |||||||||
| Account Payables | 17.6 | 15.4 | 6.6 | 4.3 | 2.1 | 1.0 | 0.7 | 1.4 | 0.7 |
| Short-Term Debt | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 8.6 | 29.0 | 27.6 | 0 | 0 | 0.3 |
| Other Current Liabilities | 40.9 | 30.4 | 11.8 | 0 | 0 | 0.0 | 0.1 | 0.4 | 0.7 |
| Total Current Liabilities | 58.8 | 46.1 | 27.1 | 31.7 | 45.2 | 38.6 | 6.9 | 5.4 | 2.4 |
| Non-Current Liabilities | |||||||||
| Long-Term Debt | 27.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.2 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 140.1 | 27.6 |
| Total Non-Current Liabilities | 27.6 | 18.9 | 1.1 | 6.8 | 34.7 | 61.4 | 5.7 | 140.1 | 30.8 |
| Total Liabilities | 86.4 | 64.9 | 28.2 | 38.5 | 79.8 | 100.0 | 12.6 | 145.5 | 33.2 |
| Stockholders' Equity | |||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0.0 |
| Retained Earnings | (736.5) | (622.8) | (348.4) | (235.4) | (176.7) | (127.0) | (92.5) | (50.5) | (16.2) |
| Accumulated Other Comprehensive Income | 2.3 | 0.8 | 0.6 | (2.9) | (0.7) | 0.0 | 0.1 | (0.0) | (0.0) |
| Total Stockholders' Equity | 1,022.9 | 1,059.1 | 621.1 | 349.5 | 301.5 | 198.3 | 100.4 | (48.9) | (15.7) |
| Total Liabilities & Equity | 1,109.3 | 1,124.1 | 649.3 | 388.0 | 381.3 | 298.3 | 113.0 | 96.5 | 17.5 |
| Debt Metrics | |||||||||
| Total Debt | 27.9 | 19.2 | 2.9 | 3.5 | 5.2 | 6.7 | 6.8 | 0 | 3.2 |
| Net Debt | (84.9) | (65.2) | (154.1) | (65.2) | (86.9) | (65.3) | (27.3) | (20.5) | (2.8) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Net Income | (113.7) | (274.5) | (113.0) | (58.7) | (49.8) | (34.5) | (42.0) | (34.3) | (11.9) |
| Depreciation & Amortization | 4.6 | 3.8 | 4.0 | 2.1 | 1.7 | 1.4 | 1.2 | 0.9 | 0.4 |
| Stock-Based Compensation | 0 | 34.7 | 18.5 | 11.6 | 8.2 | 3.6 | 2.2 | 0.9 | 0.1 |
| Change in Working Capital | 1.9 | 11.5 | (13.2) | (41.6) | (17.8) | 84.4 | (0.3) | 1.7 | 1.6 |
| Other Non-Cash Items | 36.1 | (23.2) | (11.6) | (0.7) | 1.8 | 0.6 | (0.5) | 4.1 | (2.4) |
| Operating Cash Flow | (71.1) | (247.6) | (115.2) | (87.2) | (55.8) | 55.5 | (39.3) | (27.6) | (12.2) |
| Investing Activities | |||||||||
| Capital Expenditure | (2.4) | (3.9) | (2.4) | (3.4) | (2.6) | (0.5) | (1.4) | (1.7) | (1.8) |
| Acquisitions | 0 | 0 | 0 | 33.4 | 67.0 | (0.0) | (0.0) | 0 | 0 |
| Purchases of Investments | (607.9) | (1,191.3) | (596.0) | (255.8) | (315.0) | (242.3) | (88.0) | (133.3) | (13.5) |
| Sales/Maturities of Investments | 680.2 | 692.6 | 439.9 | 225.8 | 248.0 | 96.6 | 91.6 | 71.8 | 6.3 |
| Other Investing Activities | 0 | 0 | 0 | (33.4) | (67.0) | 0.0 | 0.0 | 0 | 0 |
| Investing Cash Flow | 70.0 | (502.6) | (158.5) | (33.4) | (69.7) | (146.2) | 2.3 | (63.2) | (8.9) |
| Financing Activities | |||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 13.9 | 10.8 | 2.2 | 2.2 | 1.5 | 0.3 | 0.0 | 0.2 |
| Financing Cash Flow | 29.8 | 677.6 | 362.7 | 97.2 | 145.5 | 128.8 | 50.6 | 105.4 | 17.5 |
| Cash Position | |||||||||
| Net Change in Cash | 28.4 | (72.6) | 89.0 | (23.4) | 20.0 | 38.0 | 13.6 | 14.6 | (3.7) |
| Cash at Beginning | 84.4 | 157.8 | 68.7 | 92.2 | 72.1 | 34.2 | 20.6 | 6.0 | 9.7 |
| Cash at End | 112.8 | 85.2 | 157.8 | 68.7 | 92.2 | 72.1 | 34.2 | 20.6 | 6.0 |
| Free Cash Flow | (73.5) | (251.4) | (117.6) | (90.6) | (58.4) | 55.0 | (40.7) | (29.3) | (14.0) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 218.7 | 7 | 23.4 | 50.9 | 27.9 | 19.5 | 0 | 0 | 0 |
| Gross Profit | 214.1 | 3.2 | 19.4 | 48.8 | 26.2 | 18.2 | (1.2) | (0.9) | (0.4) |
| Operating Income | (159.3) | (327.0) | (134.4) | (62.5) | (50.3) | (35.3) | (44.3) | (36.4) | (14.4) |
| Net Income | (113.7) | (274.5) | (113.0) | (58.7) | (49.8) | (34.5) | (42.0) | (34.3) | (11.9) |
| EPS (Diluted) | -1.28 | -3.36 | -1.96 | -1.42 | -1.41 | -1.31 | -1.90 | -2.41 | -0.83 |
| Balance Sheet | |||||||||
| Cash & Equivalents | 112.8 | 84.4 | 157.0 | 68.6 | 92.0 | 72.0 | 34.1 | 20.5 | 6.0 |
| Total Assets | 1,109.3 | 1,124.1 | 649.3 | 388.0 | 381.3 | 298.3 | 113.0 | 96.5 | 17.5 |
| Total Debt | 27.9 | 19.2 | 2.9 | 3.5 | 5.2 | 6.7 | 6.8 | 0 | 3.2 |
| Stockholders' Equity | 1,022.9 | 1,059.1 | 621.1 | 349.5 | 301.5 | 198.3 | 100.4 | (48.9) | (15.7) |
| Cash Flow | |||||||||
| Operating Cash Flow | (71.1) | (247.6) | (115.2) | (87.2) | (55.8) | 55.5 | (39.3) | (27.6) | (12.2) |
| Capital Expenditure | (2.4) | (3.9) | (2.4) | (3.4) | (2.6) | (0.5) | (1.4) | (1.7) | (1.8) |
| Free Cash Flow | (73.5) | (251.4) | (117.6) | (90.6) | (58.4) | 55.0 | (40.7) | (29.3) | (14.0) |